Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.8%

49 terminated/withdrawn out of 557 trials

Success Rate

85.2%

-1.3% vs industry average

Late-Stage Pipeline

11%

61 trials in Phase 3/4

Results Transparency

5%

13 of 283 completed trials have results

Key Signals

76 recruiting13 with results46 terminated

Enrollment Performance

Analytics

N/A
225(66.2%)
Phase 4
34(10.0%)
Phase 2
33(9.7%)
Phase 3
27(7.9%)
Phase 1
21(6.2%)
340Total
N/A(225)
Phase 4(34)
Phase 2(33)
Phase 3(27)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (557)

Showing 20 of 557 trials
NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT06482138Not ApplicableRecruiting

Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation

Role: collaborator

NCT05859620Active Not Recruiting

Implementation of a Clinical Screening and Response System for Cardiac Complications After Noncardiac Surgery

Role: collaborator

NCT07565051Recruiting

Can Pre-operative Lean Mass Predict Weight Loss After Roux-en-Y Gastric Bypass?

Role: lead

NCT04444544Completed

Quality of Life and High-Risk Abdominal Cancer Surgery

Role: lead

NCT04543708Not ApplicableTerminated

Surgical Treatment of Tonsillar Abscess

Role: lead

NCT07531238Not ApplicableNot Yet Recruiting

Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor

Role: lead

NCT06653569Phase 3Recruiting

Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Role: collaborator

NCT07267624Not ApplicableNot Yet Recruiting

EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)

Role: lead

NCT05883540Phase 2Recruiting

Lysergic Acid Diethylamide (LSD) in Palliative Care

Role: collaborator

NCT07173127Not ApplicableRecruiting

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

Role: lead

NCT05713734Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study

Role: lead

NCT06710210Not ApplicableRecruiting

Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

Role: lead

NCT06528873Phase 4Recruiting

COMS for Chronic Ulcers Treatment

Role: collaborator

NCT07550010Not ApplicableRecruiting

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

Role: lead

NCT07436052Not ApplicableCompleted

Impact of Ten Second Triage vs. Sieve on Triage Performance in Simulated Mass-Casualty Incidents

Role: collaborator

NCT06640075Not ApplicableRecruiting

Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon

Role: collaborator

NCT05071846Phase 1Active Not Recruiting

MVX-ONCO-2 in Advanced Solid Tumors

Role: lead

NCT07524049Not Yet Recruiting

Giving Children a Voice in Paediatric Anaesthesia

Role: collaborator

NCT07506356Recruiting

Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors

Role: lead